English: A dramatic photo shot of nasal spray in action. A hand sprays a mist of nasal spray droplets on a black background. (Photo credit: Wikipedia)
Peptide holds promise of new therapeutic approach
A nasal spray that delivers a peptide to treat depression holds promise as a potential alternative therapeutic approach, research from the Centre for Addiction and Mental Health (CAMH) shows.
The study, led by CAMH’s Dr. Fang Liu, is published online in Neuropsychopharmacology.
In a previous study published in Nature Medicine in 2010, Dr. Liu developed a protein peptide that provided a highly targeted approach to treating depression that she hopes will have minimal side effects. The peptide was just as effective in relieving symptoms when compared to a conventional antidepressant in animal testing. However, the peptide had to be injected into the brain. Taken orally, it would not cross the blood-brain barrier in sufficient concentrations.
“Clinically, we needed to find a non-invasive, convenient method to deliver this peptide treatment,” says Dr. Liu, Senior Scientist in the Campbell Family Mental Health Research Institute at CAMH. With the support of a Proof of Principle grant from the Canadian Institutes of Health Research (CIHR), Dr. Liu’s team was able to further explore novel delivery methods.
The nasal delivery system, developed by U.S. company Impel NeuroPharma, was shown to deliver the peptide to the right part of the brain. It also relieved depression-like symptoms in animals.
“This study marks the first time a peptide treatment has been delivered through nasal passageways to treat depression,” says Dr. Liu, Professor in the University of Toronto’s Department of Psychiatry.
The peptide treatment interferes with the binding of two dopamine receptors – the D1 and D2 receptor complex. Dr. Liu’s team had found that this binding was higher in the brains of people with major depression. Disrupting the binding led to the anti-depressant effects.
The peptide is an entirely new approach to treating depression, which has previously relied on medications that primarily block serotonin or norepinephrine transporters.
Depression, the most common form of mental illness, is one of the leading causes of disability globally. More than 50 per cent of people living with depression do not respond to first-line medication treatment.
“This research brings us one step closer to clinical trials,” says Dr. Liu. In ongoing lab research, her team is experimenting to determine if they can make the peptide break down more slowly, and travel more quickly in the brain, to improve its anti-depressant effects.
The Latest on: Depression
[google_news title=”” keyword=”Depression” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Depression
- The effects of COVID-19 on stress, depression, and anxiety in pregnant and postpartum womenon March 22, 2023 at 10:39 pm
A recent study published in the journal Midwifery evaluated depression, stress, and anxiety in pregnant and postpartum individuals during the coronavirus disease 2019 (COVID-19) pandemic. Study: ...
- Fighting depressionon March 22, 2023 at 10:00 pm
A month later, the death of his cricketer pal Shane Warne, aged, 52 left him feeling like he was “drowning” in his life-long fight with depression. In an interview, the dad of two - who has daughters ...
- Researchers find that older adults suffering from depression age faster than their peerson March 22, 2023 at 1:27 pm
Older adults with depression are actually aging faster than their peers, UConn Center on Aging researchers report. "These patients show evidence of accelerated biological aging, and poor physical and ...
- 15 Rare Photos Taken In Manchester, New Hampshire During The Great Depressionon March 22, 2023 at 11:35 am
The Great Depression hit the Queen City hard. But as these historic photographs of Manchester, New Hampshire show, its citizens persisted.
- Depression in Alzheimer's has different risk factors than depression in those without dementiaon March 22, 2023 at 10:19 am
Depression in Alzheimer's has different risk factors than depression in older adults without the disease, finds a major new study in the Journal of Alzheimer's Disease. The University of Bristol-led ...
- Michelle Obama Reveals Her Grandmother’s Depression Was Often Confused For This. Here’s How To Spot Depressionon March 22, 2023 at 9:35 am
Like Obama's grandmother, many fail to recognize symptoms of depression in themselves or others, and fail to get the help they need to get better.
- Ed Sheeran details struggles with depression, drugs, bulimia: 'I didn't want to live anymore'on March 21, 2023 at 5:34 pm
Ed Sheeran says he sought therapy after struggling with depression, drugs and bulimia after his best friend's death and wife Cherry Seaborn's tumor.
- Lone Star Family Health Center: Understanding perinatal depression and its treatmentson March 21, 2023 at 2:16 pm
Perinatal depression is a common and debilitating condition that affects women during pregnancy and the postpartum period. The condition is characterized by feelings of sadness, loss of interest, and ...
- Verbal Skills Better Among Well-Supported Seniors With Depressionon March 21, 2023 at 9:45 am
Greater social support for older adults with depression helped boost verbal functioning, researchers reported. In a cross-sectional study, seniors with major depressive disorder tended to score higher ...
- Exercise can boost mental health – and may be as effective at treating depression as drugson March 20, 2023 at 10:37 am
Physical activity can improve mood and relieve stress. But to be considered a first-line treatment, scientists must determine the type and amount that works best ...
via Bing News
